Patients are searching for this trial right now

This page is already ranking on Google. Activate it to start receiving pre-qualified patient leads directly in your inbox.

14-day free trial · $44/mo after · Cancel anytime · Money-back guarantee

NCT05849532 · University of Illinois at Chicago

Home-based FES Training in People With Chronic Stroke

(HomeFES)

What this study is about

This project will examine the feasibility, safety and effect of home-based functional electrical stimulation (FES) applied to different lower limb muscles in combination with task-specific training on gait, balance and mobility in adults with chronic stroke.

View original scientific description

This project will examine the feasibility, safety and effect of home-based functional electrical stimulation (FES) applied to different lower limb muscles in combination with task-specific training on gait, balance and mobility in adults with chronic stroke. 30 individuals with chronic stroke will first undergo initial screening and baseline walking, mobility, balance and strength assessments in the laboratory. After determining their eligibility for the study, they will undergo 12-weeks of home-based FES and task-specific training. Following the initial screening (week 1) and pre-intervention assessment (week 2), participants will be trained in the lab for 6 sessions (week 3-4) for a FES home program and then given a FES home kit (FES device and an android tablet). Participants will then undergo home-training for 2 weeks (week 5-6) followed by mid-training assessment (week 7). Again, participants will undergo 4-weeks of home training (week 8-11) and final assessment at the end of training (week 12). This project has the following specific aims: Aim 1: To investigate the feasibility, safety and efficacy of 12-weeks of home-based FES and task-specific training in adults with chronic stroke. Aim 2: To examine the effect of 12-weeks of home-based FES and task-specific training on mobility, gait and balance (anticipatory and reactive balance) in adults with chronic stroke.

Interventions

DEVICE

Functional Electrical Stimulation

12-weeks of training sessions that include initial screening and clinical assessment (Week 1-2), onsite training sessions (Week 3-4), home training sessions (Week 4-8). There will also be pre (Week 1), mid (Week 7) and post-training (Week 12) assessment. Each session will consist of a 10-minute warm-up session with 5-6 stretching exercises. Warm-up will be followed by a 30 minute training session comprising of mobility, balance and walking exercises with FES. This will be followed by a cool down session for 10-minutes comprising of 5-6 muscle stretches. The participant will first watch video of the each exercise on the android tablet and then perform the exercises.

Primary outcome measures

Change in Dynamic balance from baseline to mid and post-training

Time frame: Baseline (Week 1), mid-training (Week 7) and immediate post-training (Week 12)

Berg Balance Scale is a 14-point scale that is widely used in the clinic and research settings to test dynamic balance in different populations. This outcome measure tests the balance during various daily living activities including sit to stand, transferring from bed to chair, reaching forward with an outstretched arm, placing alternating foot on stool amongst others. Out of a total score of 56, a score of less than 40 is considered to at moderate fall-risk in people with chronic stroke. A score more than 40 is considered as low to moderate fall-risk for participants to perform home activities. Hence, participants who score \>40 points on 56 will be qualified to transition to the independent home training sessions. Further, dynamic balance will also be assessed using the Limits-of-stability test. Here, the participant will be asked to reach multi-directional targets and their body's center of pressure excursion and movement velocity will be assessed.

Change in Functional balance from baseline to mid and post-training

Time frame: Baseline (Week 1), mid-training (Week 7) and immediate post-training (Week 12)

Mini-BESTest scale will be used to assess functional balance. This scale consists of 36-items which assess 6 balance control systems. This scale is a balance assessment tool testing dynamic and reactive balance with six components to assess 1) Biomechanical constraints 2) Stability limits/Verticality 3) Transitions/anticipatory balance 4) Reactive balance 5) Sensory orientation and 6) Stability in Gait

Change in the Timed up and go test from baseline to mid and post-training

Time frame: Baseline (Week 1), mid-training (Week 7) and immediate post-training (Week 12)

Assessed using The Timed Up and Go test, unit of assessment is seconds. The Timed Up and Go test requires the participant to stand up from a chair, walk 3 meters, turn around, come back and sit again "as quickly as possible." Lesser time indicates better functional mobility

Change in the Four square step test from baseline to mid and post-training

Time frame: Baseline (Week 1), mid-training (Week 7) and immediate post-training (Week 12)

Assessed via four square step test, unit of assessment is seconds. The four-square step test is used to assess coordination. Here, the participant is asked to step in a 4 square in clockwise and then anti-clockwise manner and the time to complete the test is recorded. Lesser time taken to complete the test indicates better functional mobility.

Change in the 30-second chair stand test from baseline to mid and post-training

Time frame: Baseline (Week 1), mid-training (Week 7) and immediate post-training (Week 12)

Assessed via 30-second chair stand test, unit of assessment is number. The participant is asked to stand from a chair and sit down as fast as they can and as many times as they can and the number of repetitions is recorded. More repetitions indicate more functional mobility.

Change in functional reaching from baseline to mid and post-training

Time frame: Baseline (Week 1), mid-training (Week 7) and immediate post-training (Week 12)

This test requires the participant to reach forward with their arms stretched by moving their weight on their toes without bending their back or knees. Functional-reach test is used as an outcome to assess risk of falling.

Change in volitional balance via Sensory organization testing from baseline to mid and post-training

Time frame: Baseline (Week 1), mid-training (Week 7) and immediate post-training (Week 12)

Posturography for assessing balance six conditions (SOT): under condition 1 (eyes open), and condition 2 (eyes closed), both the platform and the surround remain immobilized. Under condition 3, the surround moves. Under condition 4, the platform moves and the surround remains fixed. Under condition 5, the platform moves while the subject keeps his/her eyes closed. Under condition 6, both the surround and the platform move.

Change in isometric muscle strength from baseline to mid and post-training

Time frame: Baseline (Week 1), mid-training (Week 7) and immediate post-training (Week 12)

Isometric muscle strength of bilateral hip, knee and ankle muscles is assessed using the Biodex dynamometer machine.

Change in muscle spasticity from baseline to mid and post-training

Time frame: Baseline (Week 1), mid-training (Week 7) and immediate post-training (Week 12)

Stroke-related muscle spasticity is assessed via Modified Ashworth Scale, which is a universal scale used to test spasticity. The scale is graded ranging from points 0-4 with 0 indicating no increase in muscle tone and 4 indicating that affected part is rigid in flexion and extension

Change in the Chedoke McMaster impairment from baseline to mid and post-training

Time frame: Baseline (Week 1), mid-training (Week 7) and immediate post-training (Week 12)

The Chedoke Mcmaster Assessment Scale (CMSA) (Leg and Foot Subscale). The CMSA Leg and Foot subscale, are 7-point scale each, which assess the severity of motor impairment based on Brunnstorm Stages of Motor recovery. A score of ≥4/7 is considered as low impairment in individuals with stroke.

Change in the Fugl-Meyer lower extremity scale from baseline to mid and post-training

Time frame: Baseline (Week 1), mid-training (Week 7) and immediate post-training (Week 12)

The Fugl-Meyer Assessment is a stroke-specific, performance-based index that assesses sensorimotor function, joint positioning and functioning. Total scoring is of 86 points with higher points indicating higher function.

Change in the Modified Rankin scale from baseline to mid and post-training

Time frame: Baseline (Week 1), mid-training (Week 7) and immediate post-training (Week 12)

The modified Rankin scale is 7-point measure of global disability used to assess functional disability after stroke. A score of 0 is considered as no disability whereas a score of 5 is considered as severe disability requiring constant medical care and a score of 6 indicating death.

Change in peripheral sensation from baseline to mid and post-training

Time frame: Baseline (Week 1), mid-training (Week 7) and immediate post-training (Week 12)

Peripheral sensations will be assessed using the Semmes-Weinstein Monofilament testing. Inability to perceive the 5.07/10g filament indicates loss of lower limb protective sensations.

Change in physical activity from baseline to mid and post-training

Time frame: Baseline (Week 1), mid-training (Week 7) and immediate post-training (Week 12)

Physical activity is assessed using the Physical Activity Scale for the Elderly (PASE). PASE scale is a brief 5-minute survey that is designed to assess physical activity in the last 7 days. The PASE assesses different types of activities, exercise, housework, yard work, recreational activities and caring for others. The PASE scale grading ranges from a a score of 0-793. Higher score indicates greater physical activity.

Change in balance confidence from baseline to mid and post-training

Time frame: Baseline (Week 1), mid-training (Week 7) and immediate post-training (Week 12)

Participant's balance confidence is assessed using: The Activities-specific Balance Confidence (ABC) Scale. The ABC is a 16-point scale that assesses participant perceived balance confidence during daily living activities ranging from walking around the house to walking outside on icy sidewalks. Each of the 16-points can be graded in terms of percentage with 0 indicating no confidence and 100 indicating complete confidence of not losing balance or becoming unsteady while performing the activity. Higher score indicates higher balance confidence.

Change in community participation from baseline to mid and post-training

Time frame: Baseline (Week 1), mid-training (Week 7) and immediate post-training (Week 12)

This is assessed by community integration questionnaire that assesses an individual's community integration using three domains: 1) home and 2) social integration and 3) productive activity. Higher score indicates better community participation.

Change in overall health status from baseline to mid and post-training

Time frame: Baseline (Week 1), mid-training (Week 7) and immediate post-training (Week 12)

The Short Form 36 Health Survey will be used for assessment of overall health. The SF-36 has 8-sections scores ranging from 0-100. The 8-sections include: 1) vitality 2) physical functioning 3) Bodily pain 4) General Health perceptions 5) Physical role functioning 6) Emotional role functioning 7) Social role functioning and 8) Mental Health. Higher score indicates better health status.

Change in overground gait speed from baseline to mid and post-training

Time frame: Baseline (Week 1), mid-training (Week 7) and immediate post-training (Week 12)

Overground gait speed is assessed using the 10-Meter walk test. Participants will walk for 10-meter with and without assistive device at their comfortable walking speed

Change in global cognition from baseline to mid and post-training

Time frame: Baseline (Week 1), mid-training (Week 7) and immediate post-training (Week 12)

The Montreal Cognitive assessment scale examines different domains of cognitive function like memory, attention, orientation and language and are scored ranging from 0-30 points. Higher score indicates great cognitive function. \< 19 out of 30 indicates cognitive impairment, 19-25 indicates mild cognitive impairment and above 25 indicates intact cognition.

Change in general cognition from baseline to mid and post-training

Time frame: Baseline (Week 1), mid-training (Week 7) and immediate post-training (Week 12)

Assessed using the Mini-Mental Assessment Scale (MMSE). The MMSE is a 30-point scale that tests general cognition required to perform everyday living activities. More points indicate higher cognition. A score over 26 indicates higher cognition

Change in laboratory induced falls from baseline to mid and post-training

Time frame: Baseline (Week 1), mid-training (Week 7) and immediate post-training (Week 12)

Perturbation is induced successfully and safely to reproduce inadvertent falls in a protective laboratory environment. Falls will be measured by amount of force recorded on the load cell attached to the ceiling mounted safety harness system donned by the participant. Instability of the body's COM and poor limb support prior to touchdown of the recovery step account for 90\~100% of subsequent falls (occurring \~500ms later) during treadmill-induced stance slip.

Change in center of mass stability from baseline to mid and post-training

Time frame: Baseline (Week 1), mid-training (Week 7) and immediate post-training (Week 12)

Stability is defined by both the position of a person's center-of-mass (COM) with respect to his or her base-of-support (BOS) and it's velocity. This will be assessed during treadmill-induced stance slips.

Change in limb support from baseline to mid and post-training

Time frame: Baseline (Week 1), mid-training (Week 7) and immediate post-training (Week 12)

The inability to provide timely limb support due to insufficient amount of upward impulse generated from the ground reactive force can cause limb collapse, as characterized by the quotient of amount and rate of hip descent (Vhip/Zhip) measured from hip height and lead to an eventual fall.

Change in fatigue from baseline to mid and post-training

Time frame: Baseline (Week 1), mid-training (Week 7) and immediate post-training (Week 12)

Fatigue is assessed using the Fatigue severity scale is a 9-point scale that includes statements regarding an individual's fatigue. The individual grades each statement on a scale of 0-7 with 0 indicating completely disagree and 7 indicating completely agree. Higher score indicates higher fatigue levels with total possible scoring of 63.

Change in falls efficacy from baseline to mid and post-training

Time frame: Baseline (Week 1), mid-training (Week 7) and immediate post-training (Week 12)

Falls efficacy is assessed using The Falls Efficacy Scale consisting of 10 activities of dialy living. For each of the activities, the participant has to score on a scale of 1 to 10, 1 being very confident and 10 being not confident at all, how confident is the participant that they can do the activity without falling? Lower score indicates higher confidence. A total score of greater than 70 indicates that the person has a fear of falling.

Change in maximum loading threshold from baseline to mid and post-training

Time frame: Baseline (Week 1), mid-training (Week 7) and immediate post-training (Week 12)

The spring-scale test is used to assess the maximum loading threshold for reactive balance. Participant will undergo balance testing in standing where the researcher will deliver waist-pull perturbations in anterior and posterior direction. The maximum loading threshold is the weight at which the participant can maintain their balance without stepping.

Change in maximum stepping threshold from baseline to mid and post-training

Time frame: Baseline (Week 1), mid-training (Week 7) and immediate post-training (Week 12)

The spring-scale test is used to assess the maximum stepping threshold for reactive balance. Participant will undergo balance testing in standing where the researcher will deliver waist-pull perturbations in anterior and posterior direction. The maximum stepping threshold is the weight at which participant takes a step even after resisting the waist-pull perturbation.

Who can participate

This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.

Inclusion criteria

  • Age group: 18-90 years.
  • Presence of unilateral hemiparesis.
  • Onset of stroke (\> 6 months).
  • Ability to walk independently with or without an assistive device for at least 300 ft.
  • Can understand and communicate in English and can verbalize discomfort or pain in English
  • Use of smartphone on a daily basis
  • Availability of internet/Wi-Fi at home

Exclusion criteria

  • Body weight more than 250 lbs.
  • Heel bone density measurement using an ultrasound device. Individuals classified as osteoporotic (i.e., with a T-score \< -2) will be excluded.
  • Cognitive impairment (Montreal Cognitive assessment score \<26/30)
  • Verbal Aphasia (i.e \<71% score on Mississippi Aphasia Screening)
  • Severe depression (\> 15 points on geriatric depression scale)
  • Any neurological condition other than stroke.
  • Uncontrolled and/or untreated hypertension/hypotension, uncontrolled and/or untreated diabetes and any musculoskeletal, neuromuscular or systemic diagnosis .
  • Recent major surgery (\< 6 months) or hospitalization (\< 3 months).
  • Deep venous thrombosis.
  • Past or current history of any type of active cancer
  • Peripheral nerve injury or neuropathy in the affected limb with motor disability.
  • Uncontrolled high blood pressure/angina.
  • Skin condition not tolerant with FES therapy.
  • Past or current history of uncontrolled/controlled epilepsy or any other types of seizure disorders
  • Botox treatment within the last 5 months.
  • Pacemaker users. \-

Where

  • Chicago, Illinois

Related conditions & keywords

Chronic StrokeFunctional electrical stimulationHome-training

Frequently asked questions

What is a clinical trial?

A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.

Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.

Will I be compensated?

Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.

Will I receive a placebo instead of treatment?

When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.

Can I leave a trial if I change my mind?

Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.

How long does a clinical trial last?

Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.

Data: ClinicalTrials.gov · synced Jul 8, 2026 · Source of record for eligibility and locations

📊
1 of 30 participants interested
3% interest

See if this study fits

A short prescreen based on this study's listed criteria. A coordinator confirms eligibility — this is not a medical assessment.

Preparing your pre-screening questions…

Study locations

Choose your preferred location, or select flexible during enrollment.

RECRUITING

Chicago

Illinois

Location available

Express your interest

Share your contact details and a study coordinator can follow up about screening.

Secure & Confidential

Your information is protected and will only be shared with the research team.

What participation can include

  • Study-related care provided by the research team
  • Close monitoring by medical professionals
  • Possible compensation for time and travel*
  • The option to withdraw at any time
  • Contributing to medical research that may help future patients

*Compensation varies by study. Confirm details with coordinator.

Typical next steps

  1. 1.Submit this form
  2. 2.Phone screening
  3. 3.In-person assessment if eligible
  4. 4.Begin participation

Find More Stroke Trials by City

Browse all stroke clinical trials in these cities — not just this study.

Looking for Chronic Stroke Treatment in Chicago?

Join others in Illinois exploring innovative treatment options through clinical research

Chronic Stroke Treatment Options in Chicago, Illinois

If you're searching for Chronic Stroke treatment in Chicago, participating in a clinical research study may provide access to innovative approaches under expert medical supervision. This study is actively recruiting participants in Chicago and surrounding areas.

Clinical trials offer participants the opportunity to receive cutting-edge treatments while contributing to medical research that may help future patients with Chronic Stroke. All study-related care is provided at no cost to participants.

Local Sites
1 locations in Illinois
Now Enrolling
Up to 30 participants
Quick Start
Screening available now

Why Consider a Clinical Trial for Chronic Stroke?

Potential Benefits

  • Access to new treatment approaches before public availability
  • Close monitoring by experienced medical professionals
  • Study-related care provided at no cost
  • Contribute to medical research for Chronic Stroke

What to Expect

  • Initial screening to determine eligibility
  • Regular check-ups and monitoring visits
  • Possible compensation for time and travel
  • You can withdraw at any time

Frequently Asked Questions About This Chronic Stroke Study

Important Clinical Trial Information

This information is provided for educational purposes and does not constitute medical advice. Clinical trial participation involves potential risks and benefits. Eligibility requirements apply and will be assessed during the screening process.

Study identifier: NCT05849532. For complete study details, visit ClinicalTrials.gov. Always consult with your healthcare provider before making decisions about your medical care or participating in clinical research.